Dusan Petrovic
Overview
Explore the profile of Dusan Petrovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nikolic N, Basica B, Strbac M, Terzic L, Patic A, Kovacevic G, et al.
Medicina (Kaunas)
. 2024 Jun;
60(6).
PMID: 38929539
: Human papillomavirus (HPV) infection and its etiological role in the development of cervical cancer are well established. The cervical cancer mortality rate in Serbia is one of the highest...
2.
Carlino L, Astles P, Ackroyd B, Ahmed A, Chan C, Collie G, et al.
J Med Chem
. 2024 May;
67(11):8962-8987.
PMID: 38748070
Dysregulation of histone methyl transferase nuclear receptor-binding SET domain 2 (NSD2) has been implicated in several hematological and solid malignancies. NSD2 is a large multidomain protein that carries histone writing...
3.
Ghobril J, Petrovic D, Ehret G, Ponte B, Pruijm M, Ackermann D, et al.
Chimia (Aarau)
. 2023 Dec;
76(12):1052-1062.
PMID: 38069802
The recent advent of high-throughput sequencing technologies has allowed exploring the contribution of thousands of genomic, epigenomic, transcriptomic, or proteomic variants to complex phenotypic traits. Here, we sought to conduct...
4.
Petrovic D, Bankir L, Ponte B, Pruijm M, Corre T, Ghobril J, et al.
Nephrol Dial Transplant
. 2023 Jun;
39(1):122-132.
PMID: 37381173
Background: Evaluation of renal function and of factors associated with its decline are important public health issues. Besides markers of glomerular function [e.g. glomerular filtration rate (GFR)], those of tubular...
5.
McCrory C, McLoughlin S, Layte R, NiCheallaigh C, OHalloran A, Barros H, et al.
Psychoneuroendocrinology
. 2023 Apr;
153:106117.
PMID: 37100008
Background: Allostatic load (AL) is a multi-system composite index for quantifying physiological dysregulation caused by life course stressors. For over 30 years, an extensive body of research has drawn on...
6.
Schwob J, Miauton A, Petrovic D, Perdrix J, Senn N, Gouveia A, et al.
PLoS One
. 2023 Feb;
18(2):e0282150.
PMID: 36827328
Background: Nasopharyngeal antigen Rapid Diagnostic Tests (RDTs), saliva RT-PCR and nasopharyngeal (NP) RT-PCR have shown different performance characteristics to detect patients infected by SARS-CoV-2, according to the viral load (VL)-and...
7.
Chamberlain J, Nussle S, Chapatte L, Kinnaer C, Petrovic D, Pradervand S, et al.
Clin Epigenetics
. 2022 Nov;
14(1):155.
PMID: 36443762
Background: Smoking and alcohol consumption may compromise health by way of epigenetic modifications. Epigenetic signatures of alcohol and tobacco consumption could provide insights into the reversibility of phenotypic changes incurred...
8.
Petrovic D, Carmeli C, Sandoval J, Bodinier B, Chadeau-Hyam M, Schrempft S, et al.
Psychoneuroendocrinology
. 2022 Nov;
147:105976.
PMID: 36417838
Adverse socioeconomic circumstances negatively affect the functioning of biological systems, but the underlying mechanisms remain only partially understood. Here, we explore the associations between life-course socioeconomic factors and four markers...
9.
Weiergraber O, Petrovic D, Kislat A, Pattky M, Fabig J, Batra-Safferling R, et al.
Biomolecules
. 2022 Nov;
12(11).
PMID: 36358937
Human C-C motif ligand 16 (CCL16) is a chemokine that is distinguished by a large cleavable C-terminal extension of unknown significance. Conflicting data have been reported concerning its tissue distribution...
10.
Petrovic D, Scott J, Bodnarchuk M, Lorthioir O, Boyd S, Hughes G, et al.
J Chem Inf Model
. 2022 Aug;
62(16):3832-3843.
PMID: 35920716
ROS1 rearrangements account for 1-2% of non-small cell lung cancer patients, yet there are no specifically designed, selective ROS1 therapies in the clinic. Previous knowledge of potent ROS1 inhibitors with...